(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MEDLASER USA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MEDLASER USA

ST13

US500000087339892

Class

10

Filing

87339892

Registration

5582455

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

40

Latest update

07/18/2025

Trademark type

Word

Nice classes

10

Filing date

02/17/2017

Registration date

10/09/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/17/2025

Last transaction

07/18/2025

Responsible office

United States Patent and Trademark Office

Status code

701

Official register

Supplemental Register

First use anywhere

05/22/2016

First use in commerce

05/22/2016

Drawing code

4

Owner type

01

Owner location

CLEARWATER, FL

Examiner

O'BRIEN, JENNIFER

Current location

Historical data usage

Holders and representatives

Holders

BARUCH, JASON
MedLaser Discount, LLC

Representatives

Bradley S. Rothschild Rothschild & Associates LLC

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Aesthetic medical lasers

Publications

History of USPTO decisions and trademark events.

40 publications found

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

07/17/2025

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

07/17/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/17/2025

ES8R

TEAS SECTION 8 RECEIVED

04/08/2025

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

10/09/2023

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

01/15/2020

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

10/09/2018

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

09/05/2018

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

08/29/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

08/29/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/29/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

08/29/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/29/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/08/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/07/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/07/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/03/2018

GNRT

NON-FINAL ACTION E-MAILED

05/03/2018

CNRT

NON-FINAL ACTION WRITTEN

05/03/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/18/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/18/2018

ALIE

ASSIGNED TO LIE

04/12/2018

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/02/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/02/2018

NREV

NOTICE OF REVIVAL - E-MAILED

03/30/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/30/2018

PETG

PETITION TO REVIVE-GRANTED

03/30/2018

PROA

TEAS PETITION TO REVIVE RECEIVED

03/30/2018

MAB2

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

12/18/2017

ABN2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

12/16/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/05/2017

UNDN

UNDELIVERABLE MAIL - NO ACTION TAKEN

06/30/2017

UNDC

UNDELIVERABLE MAIL - COURTESY COPY MAILED

05/25/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/20/2017

GNRT

NON-FINAL ACTION E-MAILED

05/20/2017

CNRT

NON-FINAL ACTION WRITTEN

05/20/2017

DOCK

ASSIGNED TO EXAMINER

05/12/2017

MPMK

NOTICE OF PSEUDO MARK E-MAILED

02/25/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/24/2017

NWAP

NEW APPLICATION ENTERED

02/21/2017

Continuous trademark protection

Get notified about every new filing that threatens MEDLASER USA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.